Dextropropoxyphene is an opioid analgesic manufactured by Eli Lilly and Company. It is used in the symptomatic treatment of mild pain. It displays antitussive and local anaesthetic actions. Due to the risk of cardiac arrhythmias and overdose, possibly leading to death, dextropropoxyphene has been withdrawn from the market in Europe and the United States. The drug is often referred to as the general form, “propoxyphene”, however only the dextro-isomer (dextropropoxyphene) has any analgesic effect. The levo-isomer appears to exhibit a very limited antitussive effect. Its therapeutic use is listed as analgesics. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Dextropropoxyphen and Algafan. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 10100.
Propoxyphene
| CAS No | 469-62-5 |
|---|---|
| Molecular Formula | C22H29NO2 |
| Molecular Weight | 339.5 g/mol |
| Synonyms | [(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Dextropropoxyphene is an opioid analgesic manufactured by Eli Lilly and Company. It is used in the symptomatic treatment of mild pain. It displays antitussive and local anaesthetic actions.
The listed CAS number is 469-62-5.
The listed molecular formula is C22H29NO2.
The listed molecular weight is 339.5 g/mol.
[(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate.
The source lists Dextropropoxyphen and Algafan.